PD-1 Blockade Plus Chemo Extends Pancreatic Cancer EFS
Summary
A single-center randomized trial paired a checkpoint inhibitor with a four-drug chemotherapy backbone in pancreatic tumors abutting major vessels. The benefit split sharply by resectability class.
Description from Medscape.
Who is covering this
-
PD-1 Blockade Plus Chemo Extends Pancreatic Cancer EFS
A single-center randomized trial paired a checkpoint inhibitor with a four-drug chemotherapy backbone in pancreatic tumors abutting major vessels. The benefit split sharply by resectability class.
Comments
Comments need JavaScript.